HA491 METHOD OF INHIBITING VASOSPASM AND PLATELET AGGREGATION RESULTING FROM ANGIOPLASTY USING THROMBOXANE A2 RECEPTOR ANTAGONISTS A method is provided for inhibiting vasospasm and platelet aggregation resulting from angioplasty by administering a thromboxane A2 receptor antagonist before, during and/or after the angioplasty procedure, which thromboxane A2 receptor antagonist is a 7-oxabicycloheptane prostaglandin analog.
METHOD OF INHIBITING VASOSPASM AND PLATELET AGGREGATION RESULTING FROM ANGIOPLASTY USING THROMBOXANE A RECEPTOR ANTAGONISTS